Icahn School of Medicine at Mount Sinai-ko ikertzaileekin lankidetzan egindako argitalpenak (30)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs

    npj Vaccines, Vol. 8, Núm. 1

2021

  1. SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?

    Journal of Experimental Medicine, Vol. 218, Núm. 6

  2. The minimal clinically important change in the motor section of the Burke-Fahn-Marsden Dystonia Rating Scale for generalized dystonia: Results from deep brain stimulation

    Parkinsonism and Related Disorders, Vol. 93, pp. 85-88

2020

  1. Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay

    Vaccine, Vol. 38, Núm. 8, pp. 1953-1961

  2. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  3. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  4. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

    Cell Reports Medicine, Vol. 1, Núm. 8

2019

  1. Broadly cross-reactive, nonneutralizing antibodies against influenza B virus hemagglutinin demonstrate effector function-dependent protection against lethal viral challenge in mice

    Journal of Virology, Vol. 93, Núm. 6

  2. Viral Fitness Landscapes in Diverse Host Species Reveal Multiple Evolutionary Lines for the NS1 Gene of Influenza A Viruses

    Cell Reports, Vol. 29, Núm. 12, pp. 3997-4009.e5

2018

  1. Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation

    Vaccine, Vol. 36, Núm. 9, pp. 1146-1153

  2. Influenza virus infection causes global RNAPII termination defects

    Nature Structural and Molecular Biology, Vol. 25, Núm. 9, pp. 885-893

  3. Specific mutations in the PB2 protein of influenza A virus compensate for the lack of efficient interferon antagonism of the NS1 protein of bat influenza A-like viruses

    Journal of Virology, Vol. 92, Núm. 7

2017

  1. Subcellular localizations of RIG-I, TRIM25, and MAVS complexes

    Journal of Virology, Vol. 91, Núm. 2

2015

  1. Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer models

    Molecular Cancer Therapeutics, Vol. 14, Núm. 5, pp. 1247-1258

  2. Novel bat influenza virus NS1 proteins bind double-stranded RNA and antagonize host innate immunity

    Journal of Virology, Vol. 89, Núm. 20, pp. 10696-10701

  3. The ns1 protein: A multitasking virulence factor

    Current Topics in Microbiology and Immunology, Vol. 386, pp. 73-107

2014

  1. A single amino acid substitution in the novel H7N9 influenza a virus NS1 protein increases CPSF30 binding and virulence

    Journal of Virology, Vol. 88, Núm. 20, pp. 12146-12151

  2. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes

    Journal of Virology, Vol. 88, Núm. 11, pp. 6213-6223

  3. The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type i interferon

    Cell Host and Microbe, Vol. 16, Núm. 3, pp. 314-327